Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 17 04:00PM ET
64.97
Dollar change
0.00
Percentage change
0.00
%
Index- P/E- EPS (ttm)-0.69 Insider Own32.43% Shs Outstand68.60M Perf Week0.05%
Market Cap4.46B Forward P/E- EPS next Y-1.90 Insider Trans-13.83% Shs Float67.74M Perf Month0.84%
Income-36.84M PEG- EPS next Q-0.43 Inst Own72.51% Short Float5.74% Perf Quarter107.84%
Sales56.52M P/S78.86 EPS this Y-170.31% Inst Trans35.35% Short Ratio1.65 Perf Half Y414.41%
Book/sh5.08 P/B12.80 EPS next Y-9.97% ROA-11.59% Short Interest3.89M Perf Year657.23%
Cash/sh4.46 P/C14.58 EPS next 5Y- ROE-14.67% 52W Range8.33 - 65.00 Perf YTD240.87%
Dividend Est.- P/FCF- EPS past 5Y24.56% ROI-10.79% 52W High-0.05% Beta0.85
Dividend TTM- Quick Ratio9.56 Sales past 5Y171.70% Gross Margin98.97% 52W Low679.95% ATR (14)0.69
Dividend Ex-Date- Current Ratio9.56 EPS Y/Y TTM59.41% Oper. Margin-90.86% RSI (14)83.31 Volatility0.05% 0.16%
Employees142 Debt/Eq0.03 Sales Y/Y TTM118.89% Profit Margin-65.17% Recom3.00 Target Price65.00
Option/ShortYes / No LT Debt/Eq0.03 EPS Q/Q-0.32% Payout- Rel Volume0.00 Prev Close64.97
Sales Surprise216.76% EPS Surprise35.63% Sales Q/Q-25.09% EarningsMay 09 AMC Avg Volume2.36M Price64.97
SMA200.38% SMA5023.78% SMA200147.28% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Apr-09-24Initiated Guggenheim Buy $55
Feb-15-24Initiated Wolfe Research Outperform $44
Oct-18-23Initiated Berenberg Buy $18
Oct-17-23Initiated Berenberg Buy $18
Oct-05-23Initiated RBC Capital Mkts Outperform $19
Jun-26-23Resumed Oppenheimer Outperform $14
Jan-19-23Initiated Morgan Stanley Overweight $17
Nov-21-22Initiated SVB Leerink Outperform $15
Dec-21-20Initiated H.C. Wainwright Buy $21
Aug-26-20Initiated Cowen Outperform
May-10-24 03:32PM
12:46PM
May-09-24 10:56PM
04:00PM
May-07-24 11:24AM
09:50AM Loading…
09:50AM
03:08AM
May-06-24 08:45PM
May-03-24 08:45AM
May-02-24 10:01AM
Apr-25-24 11:28AM
Apr-18-24 08:30AM
Apr-15-24 03:43PM
09:15AM
Apr-13-24 05:29AM
12:36PM Loading…
Apr-12-24 12:36PM
10:55AM
Apr-11-24 04:43PM
04:29PM
04:18PM
01:59PM
01:07PM
11:58AM
11:03AM
09:47AM
09:47AM
09:39AM
07:34AM
Apr-10-24 10:34PM
07:05PM
05:47PM Loading…
05:47PM
05:14PM
04:19PM
04:16PM
04:15PM
04:06PM
04:01PM
01:34PM
Apr-09-24 09:23AM
Apr-01-24 09:00AM
Mar-21-24 07:45AM
Mar-20-24 04:30PM
Mar-19-24 08:32AM
06:48AM
Mar-18-24 08:53PM
07:25PM
05:31PM
04:05PM
Mar-14-24 08:38AM
Mar-11-24 10:00AM
Mar-07-24 04:30PM
Feb-26-24 04:30PM
Feb-01-24 04:30PM
Dec-21-23 04:15PM
Dec-19-23 09:50AM
Dec-18-23 04:30PM
Dec-06-23 09:55AM
Nov-29-23 09:40AM
Nov-20-23 04:30PM
09:55AM
Nov-17-23 07:44PM
Nov-15-23 09:00AM
Nov-14-23 08:55PM
04:15PM
03:57PM
Nov-13-23 09:00AM
Nov-06-23 09:41PM
06:00AM
Nov-03-23 09:00AM
Nov-02-23 09:00AM
Oct-30-23 10:01AM
09:00AM
Oct-27-23 09:40AM
Oct-23-23 12:00PM
Oct-13-23 09:05AM
Oct-12-23 12:13PM
Oct-11-23 10:15AM
Oct-09-23 11:10AM
Oct-06-23 09:55AM
09:24AM
Oct-04-23 08:17AM
08:00AM
Oct-03-23 07:43AM
Sep-18-23 08:52AM
Sep-12-23 08:30AM
Sep-08-23 09:40AM
Sep-05-23 04:30PM
08:30AM
Aug-30-23 04:30PM
Aug-24-23 08:50AM
Aug-22-23 04:30PM
Aug-17-23 09:55AM
Aug-14-23 04:15PM
Jul-23-23 10:25AM
Jun-22-23 07:43AM
Jun-20-23 07:14PM
May-19-23 04:30PM
May-11-23 04:15PM
May-05-23 07:04AM
May-01-23 04:30PM
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing innovative, protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies. The company was founded in March 2007 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PENG STANFORD LSee RemarksMay 08 '24Option Exercise2.46271,792669,403344,163May 10 07:26 PM
DURAND REMYChief Business OfficerMay 08 '24Option Exercise5.3995,288513,869133,392May 10 07:25 PM
FUHS ULRICH MARTINChief Accounting OfficerMay 08 '24Option Exercise12.0722,820275,43730,120May 10 07:22 PM
GOLD MITCHELLExecutive Chairman and CEOMay 08 '24Option Exercise7.5513,245100,000109,245May 10 07:24 PM
Rickey James PaulSee RemarksMay 07 '24Option Exercise6.0426,761161,62957,961May 09 09:13 PM
Topper James NDirectorApr 25 '24Sale64.57191,2272,829,347Apr 29 04:32 PM
Rickey James PaulSee RemarksJan 26 '24Option Exercise8.30117,764977,84473,764Jan 29 07:04 PM
Rickey James PaulSee RemarksJan 26 '24Sale23.32117,7642,745,8300Jan 29 07:04 PM
Rickey James PaulSee RemarksJan 25 '24Option Exercise6.512361,536236Jan 29 07:04 PM
Rickey James PaulSee RemarksJan 25 '24Sale22.002365,1920Jan 29 07:04 PM
GOLD MITCHELLExecutive Chairman and CEODec 28 '23Option Exercise12.7474,441948,3782,675,421Dec 29 07:32 PM
GOLD MITCHELLExecutive Chairman and CEODec 28 '23Option Exercise0.651,0166601,016Dec 29 07:32 PM
ORBIMED ADVISORS LLCDirectorDec 28 '23Sale18.351,364,84925,049,034264,315Dec 29 04:18 PM
Thompson Peter A.DirectorDec 28 '23Sale18.351,364,84925,049,034264,315Dec 29 04:20 PM
GOLD MITCHELLExecutive Chairman and CEODec 28 '23Sale20.041,01620,3620Dec 29 07:32 PM
GOLD MITCHELLExecutive Chairman and CEODec 27 '23Option Exercise0.6529,57319,22229,573Dec 27 09:07 PM
ORBIMED ADVISORS LLCDirectorDec 27 '23Sale19.96181,4983,622,700406,609Dec 29 04:18 PM
Thompson Peter A.DirectorDec 27 '23Sale19.96181,4983,622,700406,609Dec 29 04:20 PM
GOLD MITCHELLExecutive Chairman and CEODec 27 '23Sale20.0429,573592,7170Dec 27 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 26 '23Option Exercise0.6324,48615,43624,486Dec 27 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 26 '23Sale20.2224,486495,2170Dec 27 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 22 '23Option Exercise0.4537,82517,02137,825Dec 27 09:07 PM
GOLD MITCHELLExecutive Chairman and CEODec 22 '23Sale20.4337,825772,5950Dec 27 09:07 PM
Rickey James PaulSee RemarksDec 19 '23Option Exercise5.0215,21376,36915,213Dec 21 07:35 PM
GOLD MITCHELLExecutive Chairman and CEODec 19 '23Option Exercise0.452,4021,0812,402Dec 21 07:34 PM
Rickey James PaulSee RemarksDec 19 '23Sale19.2115,213292,2220Dec 21 07:35 PM
GOLD MITCHELLExecutive Chairman and CEODec 19 '23Sale20.012,40248,0640Dec 21 07:34 PM
Rickey James PaulSee RemarksDec 18 '23Option Exercise5.021,8009,0361,800Dec 18 09:20 PM
Rickey James PaulSee RemarksDec 18 '23Sale19.001,80034,2030Dec 18 09:20 PM
Rickey James PaulSee RemarksDec 15 '23Option Exercise5.0245,387227,84345,387Dec 18 09:20 PM
Rickey James PaulSee RemarksDec 15 '23Sale19.0945,387866,3830Dec 18 09:20 PM
Rickey James PaulSee RemarksDec 14 '23Option Exercise5.0211,60058,23211,600Dec 18 09:20 PM
Rickey James PaulSee RemarksDec 14 '23Sale19.0011,600220,4060Dec 18 09:20 PM
GOLD MITCHELLExecutive Chairman and CEODec 12 '23Option Exercise0.458,6133,8768,613Dec 12 09:02 PM
GOLD MITCHELLExecutive Chairman and CEODec 12 '23Sale17.3241,063711,0260Dec 12 09:02 PM
GOLD MITCHELLExecutive Chairman and CEODec 11 '23Sale17.2668,8701,189,02732,450Dec 12 09:02 PM
GOLD MITCHELLExecutive Chairman and CEODec 08 '23Sale17.088,067137,784101,320Dec 12 09:02 PM
Rickey James PaulSee RemarksDec 06 '23Option Exercise3.236,44620,8216,446Dec 06 07:31 PM
Rickey James PaulSee RemarksDec 06 '23Sale16.086,446103,6500Dec 06 07:31 PM
Rickey James PaulSee RemarksDec 05 '23Option Exercise3.234181,350418Dec 06 07:31 PM
Rickey James PaulSee RemarksDec 05 '23Sale16.014186,6940Dec 06 07:31 PM
Rickey James PaulSee RemarksDec 04 '23Option Exercise3.2363,947206,54963,947Dec 06 07:31 PM
Rickey James PaulSee RemarksDec 04 '23Sale16.0663,9471,026,8870Dec 06 07:31 PM
Rickey James PaulSee RemarksNov 30 '23Option Exercise3.237002,261700Dec 01 05:00 PM
Rickey James PaulSee RemarksNov 30 '23Sale16.0070011,2000Dec 01 05:00 PM
Rickey James PaulSee RemarksNov 06 '23Option Exercise3.2310,98935,49418,003Nov 08 05:20 PM
Rickey James PaulSee RemarksNov 06 '23Sale16.0318,003288,5540Nov 08 05:20 PM